Minocycline for chronic autoimmune eye inflammation
Treatments studied
Part of Eyes & vision clinical trials.
This trial tests whether minocycline, an antibiotic that can also reduce inflammation, helps improve chronic autoimmune uveitis and protect vision. It may help by lowering ongoing immune irritation that damages the eye.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 60 years old.
- You have an autoimmune disease affecting the eyes (autoimmune uveitis) with vision damage.
- You can sign consent and attend all scheduled study visits.
- You do not have an allergy to minocycline or other tetracycline antibiotics.
- Your liver, heart, kidney, and thyroid tests are normal enough for study treatment.
- You are not taking pregnancy-protecting or ongoing immune medicines like steroids or other immune-suppressing drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether people with chronic uveitis (eye inflammation) who have been stable on adalimumab (a biologic medicine) for at least 24 weeks can safely reduce their dose. The goal is to see if a lower dose can still control the inflammation while reducing side effects and costs.
This trial tests whether a small steroid implant placed inside the eye (YUTIQ 0.18 mg) can control chronic non-infectious uveitis. It may help reduce active inflammation and prevent flare-ups, as long as you’ve had recent signs of active disease and can follow the medication and eye-visit rules.
This study tests a new drug (GenSci048) for people with active, non-infectious uveitis in the middle or back of the eye, who are already taking oral steroids. The goal is to see if the drug can better control inflammation and reduce the need for steroids.
This study looks at children with long-term eye inflammation that is not caused by an infection. It aims to learn more about the condition and how to better help patients.
This study tests a drug called adalimumab, which helps calm the immune system, when added to the steroid medicine you may already be taking. It aims to see if this combination is safe and works better for people with Behçet's disease that affects the back of the eye and has recently flared up.
This trial uses a new genetic test to find the cause of eye inflammation when standard tests haven't. The goal is to see if this approach can identify hidden infections and help doctors choose the right treatment to protect your vision.
Hear when a new Minocycline trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.